Filing Details

Accession Number:
0001628280-18-006899
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-17 15:35:11
Reporting Period:
2018-05-15
Accepted Time:
2018-05-17 15:35:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640500 Jennifer Balliet 12701 Commonwealth Drive Suite 9
Fort Myers FL 33913
Vp And Chief Culture Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-15 13,000 $4.78 13,000 No 4 M Direct
Common Stock Disposition 2018-05-15 6,500 $11.21 6,500 No 4 S Direct
Common Stock Disposition 2018-05-15 6,500 $11.26 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-05-15 13,000 $0.00 13,000 $4.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,000 2016-05-04 2020-05-04 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $7.15 2017-04-20 2021-04-20 50,000 50,000 Direct
Common Stock Restricted Stock $0.00 2018-05-25 20,000 20,000 Direct
Common Stock Stock Option (Right to Buy) $8.03 2019-02-26 2023-02-26 72,500 72,500 Direct
Common Stock Stock Option (Right to Buy) $7.52 2018-04-28 2022-04-28 60,000 60,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-20 50,000 50,000 Direct
20,000 20,000 Direct
2023-02-26 72,500 72,500 Direct
2022-04-28 60,000 60,000 Direct
Footnotes
  1. On May 4, 2015, Jennifer Balliet was granted 120,000 stock options,these options vest ratably over the first three anniversary dates of the grant date. On March 26, 2018, 7,000 of these options were exercised leaving a balance of 113,000 options.
  2. On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  3. Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
  4. Restricted stock will vest as follows; 6,666 units will vest on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020.
  5. These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.
  6. On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date.
  7. On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.